Company News

Feb 02, 2012 display BioBusiness Track: Dr. Claudia Zylberberg will be the Co-Chair of BioBusiness Track at BioFlorida Annual Conference Oct 7-9 2012

Jan 31, 2012 display Akron Biotech hits BioPartnering North America!: Akron Biotech will be taking part in the 10th Annual BioPartnering North America meeting in Vancouver, British Columbia on February 26th, 27th and 28th!

"This is an exciting time for us as we grew substantially in 2011 and have a number of great projects in the pipeline for 2012. We will be showcasing upcoming products developed in collaboration with some of the leading institutions in the world, as well as our cutting-edge advances in cellular therapy.

Jan 31, 2012 display cGMP Recombinant Proteins: cGMP Recombinant Proteins. Order Now!

Akron Biotech aims to provide the best quality at any cost when deciding to create a product or therapy. Akron strives to carefully well document and trace the products that go through our pipeline. We work very closely with our customers to fulfill their needs, whether it requires additional testing or customization.

Biological products are usually difficult to characterize, so they require careful design, manufacture and testing. Our cGMP Recombinant Proteins are carefully crafted and tested to meet regulatory and customer demands.

Jan 31, 2012 display Journal of Commercial Biotechnology: Dr. Zylberberg and her team just had their paper accepted at the Journal of Commercial Biotechnology on "Biotechnology in Argentina: Development and Resources".It will be available at Bio this year in Boston.

Jan 01, 2012 display Bovine Insulin: AKRON BIOTECH'S BOVINE INSULIN

Akron Biotech's Bovine Insulin is manufactured under USP 30 specifications and is greater than 95% pure as determined with HPLC.

Bovine Insulin, a polypeptide hormone obtained from beef pancreas and purified from an ethanol/phosphoric acid extract. It is the principal hormone responsible for regulating the cellular uptake and storage of glucose. Bovine Insulin also plays an important role in metabolism of amino acids and fatty acids, while effectively inhibiting the degradation of glycogen protein and fat. Due to these characteristics, it is commonly used as a growth factor in many mammalian cell culture systems.

Order Today While Supplies Last!

Dec 15, 2011 display Akron Biotech support WSCS 2012. Dr. Claudia Zylberberg: Akron Biotech support WSCS 2012. Dr. Claudia Zylberberg welcomed the World Stem Cell Summit 2012, coming to Palm Beach, Florida. She will be speaking at Palm Beach Convention Center along with the co-sponsors of the Summit, University of Miami and others as an industry representative of the region.

"Coming together is a beginning. Keeping together is progress. Working together is success." - Henry Ford Quote Dr. Zylberberg, at Akron Biotech, we are committed to manufacturing and marketing bio-tools and high-end stem cell culture products under cGMP for the regenerative medicine community. By participating in the World Stem Cell Summit, we are able to strengthen our commitment and gain valuable insight into the industry through sharing unique ideas and forging successful collaborations.

The World Stem Cell Summit is the largest stem cell event in North America which presents the work of the industry's experts and educators, including laboratories and advocacy groups, in a way that is easily understood by the community. The Summit covers a vast number of topics such as regulatory pathways, stem cell studies, financing, venture capital and economic development. It provides attendees with an opportunity to interact with the world's leaders in stem cell technology. With so many breakthroughs and new therapies in the stem cell arena, this is a very important event to educate the public on the importance of stem cells.

"I had the privilege to be one of the many renowned speakers at the World Stem Cell Summit 2010 in California which had an attendance of about 1,400 from all over the world, where we interact to share the success, the innovation and the challenges of this young industry" said Dr. Zylberberg. The State of Florida has made a strong commitment to the bioscience industry and has developed groups such as BioFlorida, Banner Centers for Life Sciences, among others and brought first class science to this geographic region. The state has developed initiatives to provide investment opportunities and incentives for biotech companies to move their operations to Florida, or to companies such as Akron to grow in this area. The stem cell industry is growing at a fast pace, and it is becoming part of healthcare initiatives, the Summit would provide us with worldwide exposure and strengthen Florida's role and interaction in the bioscience industry.

Oct 27, 2011 open Cell Culture Workshop

Oct 03, 2011 display USP Meeting 2011-Seattle: Akron presented "Fast, Simple and High Sensitive Real Time PCR Detection of Mycoplasma contaminating species in cell cultures"

Jun 23, 2011 open Akron Biotech support PBSC-Work Force Alliance Workshops

May 18, 2011 visit Akron will participate on the 8th Celebration of Biotechnology

May 10, 2011 display Akron Biotech has partnered with Palm Beach State College and the Banner Center for Life Sciences: Akron Biotech has partnered with Palm Beach State College and the Banner Center for Life Sciences to assist in the development of cell culture products and provide educational opportunities for biotechnology students. With funding from the Town of Jupiter, Palm Beach State College offers Entrepreneurial Assistance Program that provides laboratory access and support for area life science companies. Palm Beach State College and the Banner Center for Life Sciences will partner with Akron Biotech to develop cell culture products for the biotech industry. "This is a great opportunity to use a fully equipped facility and for us to help the training of students in novel technologies to enter the workforce in Florida," said Claudia Zylberberg, PhD. "This partnership will help to generate preliminary data for many products from our pipeline and serve the cell culture community with tools and novel products," added Dr. Zylberberg, In exchange, Akron will provide their biopharma and industrial knowledge to develop curriculum, offer training and provide internship opportunities for Biotechnology Program students at PBSC. "This partnership will provide industry exposure for our students and create an authentic workplace setting to train students for careers in the life science industry," said Libby Handel, PhD.

May 08, 2011 visit Launch Newsletter

May 05, 2011 display National BioGENEius Challenge: Jenna Pappalardo will be the only representative from Florida to compete in the U.S. National BioGENEius Challenge. The Local Florida Challenge was judged by BioFlorida members: Sandro Matosevic, PhD, Chemistry Research Associate, Scripps Research Institute; William Warren, PhD, Vice President, VaxDesign Campus; and Claudia Zylberberg, PhD, CEO, Akron Biotech... More info

Mar 03, 2011 visit Claudia Zylberberg, PhD. CEO of Akron Biotech will be a speaker at the World Stem Cell Summit